Statement from FDA Commissioner Scott Gottlieb, M.D., on efforts to safeguard women’s health from deceptive health claims and significant risks related to devices marketed for use in medical procedures for “vaginal rejuvenation”
If your email program has trouble displaying this email, view it as a web page |
U.S. Food and Drug Administration |
Comments
Post a Comment